ABBV vs VRT: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Vertiv Holdings Co — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-18.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C
High Quality
VS
Vertiv Holdings Co · Industrials
$307.34
-11.3% upside to fair value
Grade D
High Quality
QuantHub Verdict
ABBV has more upside to fair value
(+4.5%).
ABBV trades at a lower forward P/E
(14.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
VRT |
| Current Price |
$208.05 |
$307.34 |
| Fair Value Estimate |
$217.50 |
$272.65 |
| Upside to Fair Value |
+4.5%
|
-11.3%
|
| Market Cap |
$367.9B |
$117.6B |
| Forward P/E |
14.9x
|
88.2x
|
| EV / EBITDA |
16.7x
|
55.3x
|
| Price / Sales |
6.1x
|
11.5x
|
| Price / FCF |
20.9x
|
61.2x
|
| Revenue Growth YoY |
+8.6%
|
+7.6%
|
| Gross Margin |
83.7%
|
34.8%
|
| Operating Margin |
34.7%
|
18.2%
|
| Return on Equity |
-129.24%
|
40.3%
|
| Dividend Yield |
3.2% |
0% |
| FCF Yield |
4.78%
|
1.63%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
Vertiv Holdings Co operates as a global leader in digital critical infrastructure, providing technology products and solutions primarily for data centers, telecom, and AI-driven markets. The company demonstrates strong business quality with 40.3% return on equity, 7.6% revenue growth, and 11.8% earnings growth year-over-year, supported by a robust $1.89 billion free cash flow and a $15 billion ba…
Accumulation Zones
| Metric |
ABBV |
VRT |
| Zone Low |
$163.13 |
$204.49 |
| Zone High |
$184.88 |
$231.75 |
| In Buy Zone? |
No
|
No
|